• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对阿地白介素(白细胞介素-2和普乐可复)过敏,表现为面部血管性水肿和红斑。

Hypersensitivity to aldesleukin (interleukin-2 and proleukin) presenting as facial angioedema and erythema.

作者信息

Abraham Daryn, McGrath Kris G

机构信息

Division of Allergy-Immunology, Ernest S. Bazley Asthma and Allergic Diseases Center, Department of Medicine, Northwestern Memorial Hospital, USA.

出版信息

Allergy Asthma Proc. 2003 Jul-Aug;24(4):291-4.

PMID:12974198
Abstract

Aldesleukin is a human recombinant interleukin-2 product. It also is known as interlukin-2 and Proleukin in the United States. It is indicated for the treatment of adults with metastatic renal cell carcinoma as well as for adults with metastatic melanoma. However, its use has been limited because of severe systemic toxicity. There have been no reports of aldesleukin producing a hypersensitivity reaction. This is the first reported case of an immediate systemic hypersensitivity reaction occurring after aldesleukin administration confirmed by enzyme-linked immunosorbent assay for specific immunoglobulin E against aldesleukin.

摘要

阿地白介素是一种人重组白细胞介素-2产品。在美国,它也被称为白细胞介素-2和普罗力。它适用于治疗成人转移性肾细胞癌以及成人转移性黑色素瘤。然而,由于严重的全身毒性,其应用受到限制。此前尚无阿地白介素产生超敏反应的报道。这是首例经针对阿地白介素的特异性免疫球蛋白E的酶联免疫吸附测定证实,在使用阿地白介素后发生即刻全身超敏反应的病例报告。

相似文献

1
Hypersensitivity to aldesleukin (interleukin-2 and proleukin) presenting as facial angioedema and erythema.对阿地白介素(白细胞介素-2和普乐可复)过敏,表现为面部血管性水肿和红斑。
Allergy Asthma Proc. 2003 Jul-Aug;24(4):291-4.
2
Pseudosystemic sclerosis as a complication of recombinant human interleukin 2 (aldesleukin) therapy.作为重组人白细胞介素2(阿地白介素)治疗并发症的假性系统性硬化症。
Br J Dermatol. 2007 Jan;156(1):182-3. doi: 10.1111/j.1365-2133.2006.07579.x.
3
Aldesleukin. Interleukin-2 (IL-2), IL-2 (Chiron), Macrolin, Proleukin, recombinant IL-2 (Chiron), T cell growth factor.阿地白介素。白细胞介素-2(IL-2)、IL-2(凯龙公司)、大环林、普乐可复、重组IL-2(凯龙公司)、T细胞生长因子。
Drugs R D. 1999 Oct;2(4):267-70. doi: 10.2165/00126839-199902040-00012.
4
Dantrolene sodium for the treatment of aldesleukin-induced rigors in a melanoma patient.盐酸丹曲林钠治疗黑色素瘤患者白细胞介素-2 所致寒战。
Ann Pharmacother. 2012 May;46(5):e11. doi: 10.1345/aph.1Q711. Epub 2012 Apr 17.
5
Toxicity management in patients receiving low-dose aldesleukin therapy.接受低剂量阿地白介素治疗患者的毒性管理
Ann Pharmacother. 1998 Dec;32(12):1344-52. doi: 10.1345/aph.18019.
6
[Use of interleukin-2 (proleukin, aldesleukin) in oncological practice].[白细胞介素-2(普乐可复,阿地白介素)在肿瘤学实践中的应用]
Vopr Onkol. 2003;49(6):776-82.
7
[Clinical study on recombinant human interleukin-2 (Proleukin) in the treatment of metastatic renal cell carcinoma].重组人白细胞介素-2(普罗金)治疗转移性肾细胞癌的临床研究
Zhonghua Zhong Liu Za Zhi. 2008 Feb;30(2):129-33.
8
Aldesleukin for metastatic renal cell carcinoma?阿地白介素用于转移性肾细胞癌?
Drug Ther Bull. 1993 Apr 13;31(8):29-30.
9
Aldesleukin in advanced renal cell carcinoma.阿地白介素治疗晚期肾细胞癌。
Expert Rev Anticancer Ther. 2004 Dec;4(6):957-80. doi: 10.1586/14737140.4.6.957.
10
Phase I trial of BAY 50-4798, an interleukin-2-specific agonist in advanced melanoma and renal cancer.BAY 50 - 4798(一种白细胞介素-2特异性激动剂)用于晚期黑色素瘤和肾癌的I期试验。
Clin Cancer Res. 2007 Jun 1;13(11):3312-9. doi: 10.1158/1078-0432.CCR-06-1341.

引用本文的文献

1
Challenges and approaches for the development of safer immunomodulatory biologics.免疫调节生物制剂安全性开发面临的挑战与对策
Nat Rev Drug Discov. 2013 Apr;12(4):306-24. doi: 10.1038/nrd3974.